Please login to the form below
Pharma's return on R&D spend continues to slide
And cost of launching new medicine rises to $1.3bn says report
IMS Health acquires HGS Europe
Founders Graeme and Angela McFarlane bring HGS' market access services to IMS' UK team
Teva expects big things from improved drug programme
Aims to market enhanced versions of existing medicines
Roche signs $1bn-plus cancer deal with Molecular Partners
Partnership could create new type of drug conjugate similar to ADCs
Publicis buys South Africa’s Synergize
Comms group acquires African digital search marketing company
EU discusses action on stroke prevention
Stakeholders meet at European Parliament
AZ said to be eyeing Forest takeover bid
Financial Times says pharma companies are in early negotiations
Celgene signs $3.3bn cancer deal with OncoMed
Includes lead candidate demcizumab
EMA: more fee reductions for orphan drugs
Greater incentives introduced for larger companies
Smart Glasses: A new look for healthcare?
Wearable computer devices like Google Glass are tipped to become the next big technology trend, and have exciting health applications
-
Counting what countsMeasurement is the lifeblood of communications and brand investment in analytics is poised for steep growth
-
Pharma should not ignore IndiaIt’s complicated, but multinational pharma cannot ignore a market with one billion plus people
-
Sanofi's Lantus successor on trackPositive late-stage data for U300 insulin in type 2 diabetes patients
-
Forest Labs slashes staff and bolsters product portfolioNew CEO Brenton Saunders makes his mark with restructure plans
-
Biogen Idec's haemophilia candidate faces US delayFDA extends review of Alprolix
-
Takeda appoints GSK's Weber as chief operating officer Could take on CEO role next year
-
FDA backs new formulation of NoxafilMerck wins US approval for delayed-release version of anti-infective
-
Survey to gauge impact of doctor-patient talks in diabetesLilly and Boehringer sponsor worldwide study
-
Sanofi wins two at PMEA 2013Awards haul also includes four high commendations
Latest appointments
-
Janssen’s UK head moves to ChinaCesar Rodriguez appointed managing director of Xian Janssen
-
Senior appointment for FleishmanHillardJerry Tolk joins the Atlanta office as senior vice president
-
Lundbeck names SVP for business development and HRJacob Tolstrup is promoted at Danish pharma company
-
Naish leaves Novo Nordisk for MHPHealth consultancy adds several hires
-
Kleemann joins Merck from BoehringerAppointed head of group tax
Featured jobs
- Senior Brand Manager - Top 20 Pharma
- Negotiable
- CRA II & Senior CRA's - Office or Home-based
- 40,000 to 52,000 per annum
- Account Director - PR, South West London
- Extremely competitive
- Digital Project Managers
- Competitive
Subscribe to our email news alerts
PMHub
Blue Latitude
We are experts in customer engagement. A strategic multichannel marketing and customer experience agency, specialising in pharmaceuticals, medical devices, and...
Latest intelligence
- Survey: Digital Futures 2014
- Can you help us predict pharma's digital future?...
- Adherence to treatment and side effect management in breast cancer
- The success of treatment for breast cancer is dependent on a high level of adherence, however it is surprisingly common for women with breast cancer to miss doses or stop...
- ASEAN: Domestic vaccines manufacturers
- Selling vaccines in the region places commercial considerations alongside humanitarian obligations...
Quick links
